The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 26th 2024
From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
In Patients Hospitalized for Heart Failure, Hyponatremia Predicts Complications, But Not Mortality
February 18th 2014In a real-world sample of patients hospitalized for heart failure (HF), hyponatremia predicted clinical complications during admission, but it was not linked to short-term mortality or readmission.
Blood Pressure Drug Improves Functional Status of Peripheral Artery Disease Patients
February 5th 2014Among patients with peripheral artery disease and intermittent claudication, a daily dose of 10 mg ramipril can improve pain-free treadmill walking times, which are associated with a significant increase in physical functioning.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.
Thyroid Dysfunction Increases Cardiovascular Risks in Diabetic Dialysis Patients
January 24th 2014Though dialysis patients have a greater risk for thyroid disorders due to uremic toxins, protein malnutrition, and inflammation, the prevalence of those disorders and their impact on cardiovascular (CV) events and mortality have not been investigated.
Cardiology Groups Collaborating on Another Set of Hypertension Guidelines
After just releasing new hypertension guidelines, the American Society of Hypertension (ASH) is now collaborating with the American Heart Association (AHA) and the American College of Cardiology (ACC) on another set of guidelines expected to be out by the end of 2014 or early 2015.